Poland· PL-100313368

Anoro Ellipta

A vilanterol und umeclidinium bromid product containing umeclidinium + vilanterolum, registered in Poland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAnoro ElliptaATCR03AL03REGISTER NO.PL-100313368PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Vilanterol und umeclidinium bromid is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL03 (vilanterol und umeclidinium bromid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Vilanterol und umeclidinium bromid · ATC R03AL03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Umeclidinium + Vilanterolum
Manufacturer
GlaxoSmithKline (Ireland) Limited
Country
Poland (PL)
ATC code
R03AL03
ATC class
Vilanterol und Umeclidinium bromid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909991108977
  • gtin
    05909991108984
    1 inhalator po 30 dawek
    PLN 157.82
  • gtin
    05909991108991

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vilanterol und umeclidinium bromid in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vilanterol und umeclidinium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Anoro Ellipta, Laventair Ellipta
  • Liechtenstein · Anoro Ellipta, Laventair Ellipta
  • Norway · Anoro Ellipta, Laventair Ellipta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/297b6325-9d2c-433f-9385-0397f85d15d9
GET /v1/drugs/297b6325-9d2c-433f-9385-0397f85d15d9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do inhalacji, podzielony",
  "source": "urpl",
  "strength": "55 mcg + 22 mcg",
  "packaging": "05909991108977 ¦ Rp ¦ EU/1/14/898/001 ¦ 90794\n1 inhalator 7 dawek\n05909991108984 ¦ Rp ¦ EU/1/14/898/002 ¦ 90795\n1 inhalator 30 dawek\n05909991108991 ¦ Rp ¦ EU/1/14/898/003 ¦ 90796\n3 inhalatory 30 dawek",
  "substance": "Umeclidini bromidum 55 mcg + Vilanterolum 22 mcg",
  "common_name": "Umeclidinium + Vilanterolum",
  "pl_product_id": "100313368",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about vilanterol und umeclidinium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.